Panteha Behboodi, PhD

I'm a PhD bioengineer who translates novel therapeutics science into investment judgment — evaluating preclinical and clinical data, synthesizing primary literature, and stress-testing biological rationale the way I once did at the bench. That rigor comes from research spanning organ-on-chip drug discovery at Regeneron to multi-omic biomarker discovery in multiple myeloma at Hackensack Meridian Health, and now scientific due diligence at H7 BioCapital. As Growth & Initiatives Team Lead at Nucleate New York, I build the pharma-backed challenges that connect early-stage life sciences founders to the venture ecosystem — experience that sharpens how I read a founding team, not just a dataset. I'm driven by genuine curiosity about the next generation of medicines, and a conviction that sound investment decisions start with getting the science right.